Drugs / DDN-A-0101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06367426 | Apr 2024 → May 2025 | Alzheimer disease | Pharmacobio | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DDN-A-0101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06367426 ↗ |
| Route | Oral | “single dose oral administration” NCT06367426 ↗ |